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Background/Introduction
Postoperative acute kidney injury (AKI) has negative impact on patient's outcome after cardiac surgical procedures. Reported incidence of AKI requiring renal replacement therapy is approximately 1-3% of cardiac surgical patients and is characterized by extremely high morbidity and mortality rates.
Aims/Objectives
Aim of our study was to investigate perioperative factors associated with postoperative AKI requiring renal replacement therapy in patients undergone cardiac surgery.
Method
The 
Results
Univariate analysis revealed the following11 factors having statistical significant relationship with postoperative AKI requiring renal replacement therapy: Euroscore II(p < 0.01), preoperative GFR (p < 0.01), COPD (p = 0,032), ACEi use (p = 0.032), pulmonary hypertension (p = 0.01), emergent/urgent status (p < 0.01), CPB time (p < 0.01), RBC units (p < 0.01), mechanical ventilation time (p < 0.01), Prolonged inotropic support (p < 0.01) and LCOS (p < 0.01). Logistic regression analysis of the above 11 factors revealed that AKI requiring renal replacement therapy is associated with prolonged inotropic support (p < 0.00), total RBC transfused units (p < 0.00), not use of ACEi (p < 0.027).
Discussion/Conclusion
Prolonged inotropic support and total RBC transfused units are factors associated with renal replacement therapy after cardiac surgery. It seems that the use of ACEi has renal protective properties, avoiding the most serious type of AKI which demands renal replacement therapy.
